Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis.
JSON
Alimoradi Z, Sallam M, Jafari E, Potenza MN, Pakpour AH
Vaccine X 14 (-) 100308 [2023-08-00; online 2023-05-06]
Understanding COVID-19 vaccine hesitancy among migrant and refugee groups is critical for achieving vaccine equity. Therefore, we aimed to estimate the prevalence of COVID-19 vaccine acceptance among migrant and refugee populations. A systematic review (PROSPERO: CRD42022333337) was conducted (December 2019-July 2022) using PubMed, Scopus, Web of Science, ProQuest and Google Scholar. Nineteen studies from 12 countries were included. The pooled estimated prevalence of COVID-19 vaccine willingness among migrant and refugee groups was 70% (19 studies, 95% CI: 62.3-77.4%, I2: 99.19%, τ2: 0.03). Female and male participants did not differ significantly with each other (p = 0.64). Although no individual variable contributed statistically significantly in multivariable meta-regression analysis, the multivariable model that considered methodological quality, mean age of participants, participant group and country of origin explained 67% of variance. Proportions of migrant/refugee groups receiving COVID-19 vaccinations approximated those observed among general populations. Additional studies are needed to examine factors relating to vaccine willingness to identify the most significant factors that may be targeted in interventions.
Category: Social Science & Humanities
PubMed 37223070
DOI 10.1016/j.jvacx.2023.100308
Crossref 10.1016/j.jvacx.2023.100308
pmc: PMC10163798
pii: S2590-1362(23)00049-9